<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>9</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2010</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Defective T-cell Proliferation and IL-2 Production in a Subgroup of Patients with Coronary Artery Disease</title>
    <FirstPage>133</FirstPage>
    <LastPage>140</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Mahmoudi</LastName>
        <affiliation locale="en_US">Department of Nutrition and Biochemistry, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Fereydoon</FirstName>
        <LastName>Siassi</LastName>
        <affiliation locale="en_US">Department of Nutrition and Biochemistry, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Jafar</FirstName>
        <LastName>Mahmoudi</LastName>
        <affiliation locale="en_US">Division of Cardiology, Department of Internal Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Eshraghian</LastName>
        <affiliation locale="en_US">Department of Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Amir Hassan</FirstName>
        <LastName>Zarnani</LastName>
        <affiliation locale="en_US">Nanobiotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran AND  Immunology Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nima</FirstName>
        <LastName>Rezaei</LastName>
        <affiliation locale="en_US">Molecular Immunology Research Center; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran AND  Research Group for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center,  Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mona</FirstName>
        <LastName>Hedayat</LastName>
        <affiliation locale="en_US">Division of Cardiology, Department of Internal Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Fazel</FirstName>
        <LastName>Shokri</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali-Akbar</FirstName>
        <LastName>Saboor-Yaraghi</LastName>
        <affiliation locale="en_US">Department of Nutrition and Biochemistry, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Atherosclerosis is a chronic inflammatory disease of the arterial wall characterized by innate and adaptive immune responses to a variety of microbial and self-antigens. Given the crucial role of adaptive immunity in the pathogenesis of atherosclerosis, this study was performed to investigate the proliferative response of peripheral blood mononuclear cells (PBMC) and interleukin (IL)-2 production in patients with coronary artery disease (CAD). 
In this study, 25 patients with chronic stable CAD and 25 healthy individuals were investigated. The PBMCs were separated and stimulated with phytohaemagglutinin (PHA). MTT assay was performed to measure cell viability and proliferation. IL-2 concentrations in cell culture supernatants were determined by Enzyme-Linked Immunosorbent Assay. 
PHA-stimulated cells revealed a significantly increased optical density (OD) in both groups of patients (p=0.004) and controls (p</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/278</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/278/278</pdf_url>
  </Article>
</Articles>
